Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.
about
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.Antivascular therapy for epithelial ovarian cancer.Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancerModulation of the antitumor immune response by complement.Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.The renin-angiotensin system and malignancy.Prediction of therapy response in ovarian cancer: Where are we now?Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma.
P2860
Q33582300-BA49E786-4542-4096-A309-C35DA6590B61Q33583598-F2D235A3-927A-4ED8-9500-146A6837DB23Q34781970-86CBBD36-8794-4858-8BE4-52BBE5EFC1F9Q34838919-59549E54-AF20-499D-97CE-4AAAC9C0C63FQ35233993-4F4927A9-630C-4145-B81B-B0B169AB3E64Q35954103-0FC9F51C-9D95-4C7F-BAD9-F5C11D33366EQ37132001-4C0FFD38-BFAF-4789-A9DA-E6D73DD79082Q37218569-B2F00323-02F9-4632-9ED3-36D499324A66Q39263260-CB3C6C28-ED12-4EDF-A174-C87689DFAB3FQ39419250-A2ECED8F-8BC1-47C9-81A1-A4F308C50F59Q52640885-A7BF3E68-0114-427A-A4AD-8236FD4F48BA
P2860
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@ast
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@en
type
label
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@ast
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@en
prefLabel
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@ast
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@en
P2093
P2860
P356
P1476
Should tumor VEGF expression i ...... al modeling in ovarian cancer.
@en
P2093
Alisha Mohamed-Hadley
Benjamin Leiby
David O Holtz
George Coukos
Ioannis Alagkiozidis
Phyllis A Gimotty
Robert T Krafty
Wensheng Guo
P2860
P2888
P356
10.1186/1479-5876-6-2
P577
2008-01-08T00:00:00Z
P5875
P6179
1034847150